Risk Stratification Using The Society of Thoracic Surgeons Program
|
|
- Christiana Shelton
- 6 years ago
- Views:
Transcription
1 Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si M. Pham, MD, Dale N. Payne, MD, and Bartley P. Griffith, MD Division of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania In an era of progressive cost containment and public scrutiny, the wisdom of aggressive surgical therapy for high-risk candidates has been questioned. At our center in the previous 24 months, 728 patients with coronary artery disease were entered into The Society of Thoracic Surgeons national database, and the hospital outcomes plus length of stay were analyzed. Patients were separated according to the predicted mortality based on the groupings in The Society of Thoracic Surgeons database: o to 5% (453 patients); 5% to 10% (126 patients); 10% to 20% (96 patients); 20% to 30% (17 patients); and 30% and greater (36 patients). There was a dose correlation with the predicted rates of mortality. Importantly, the preoperative risk stratification demonstrated a strong correlation with the significant morbidity and excessive length of stay in the highest-risk groups (predicted risk of 20% to 2':30%). The incidences of the most common complications in the group with the highest predicted risk (2':30%) were 28%, renal failure; 33%, ventilator dependence; and 17%, cardiac arrest. In addition, at short-term follow-up (6 to 8 months), a 24.3% mortality was identified in patients with a predicted mortality that exceeded 20%. These data quantify the risks and morbidities associated with the care of seriously ill patients with coronary artery disease and demonstrate the need for professional and public discussions focusing on the association of a high preoperative risk status and the consumption of resources. (Ann Thorae Surg ) A t a time of increasing scrutiny from government agencies, third-party payers, and consumer groups, accurate, valid, and risk-stratified data with which to assess various outcome criteria are critically needed by hospitals, academic centers, and practicing cardiothoracic surgeons. To be of practical use to the clinician, a computer-based risk assessment should provide a means for accurately predicting not only the operative mortality, but also the major morbidity, the length of hospital stay, and, ultimately, the cost that the institution will incur in caring for patients in various risk categories. To this end, The Society of Thoracic Surgeons (STS) National Cardiac Surgery Database operating in more than 600 hospitals across the country now contains the records for approximately 240,000 patients who underwent isolated coronary artery surgical procedures from 1980 through 1993 [1]. This extensive repository of cases in the STS database allows for accurate statistical modeling. A portion of these stored data has been used recently to formulate a risk equation based on a detailed and exhaustive analysis of risk factors in patients undergoing isolated coronary artery operations. This has provided a tool for predicting the probability of an operative death (all deaths occurring during hospitalization or after discharge from the hospital, but within 30 days of the procedure) in any individual patient [2]. Presented at the Poster Session of the Thirtieth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 31-Feb 2, Address reprint requests to Dr Hattler, University of Pittsburgh Medical Center, 200 Lothrop st. C-700 PUH, Pittsburgh, PA by The Society of Thoracic Surgeons Whereas variate analysis identifies and weighs risk factors predictive of operative mortality, the STS risk equation looks at combinations of preoperative risk factors as they apply to the outcomes of individual patients. The sample size for anyone institution or practice group is necessarily small relative to the STS database. The grouping of patients, however, into risk categories according to the STS model allows individual hospitals and surgeons to compare their results with a large, statistically valid patient population representative of practice patterns across the United States. Using the STS database and statistical analysis package, we have analyzed our own recent experience in patients who have undergone isolated coronary artery operations. In our subset of patients, we have been able to examine not only the ability of the risk model to predict operative mortality, but also its ability to correlate various categories of risk with major morbidity and length of hospital stay. Material and Methods A total of 728 patients undergoing isolated coronary artery bypass grafting at our institution over a 2-year interval ending in October 1993 form the basis for this study. Patient variables as defined and published by the STS database were used to complete standard database forms for each patient entered into the study [3]. Two trained nurse practitioners working solely within the division of cardiothoracic surgery abstracted charts at the time of the patients' discharge. Once they were familiar with the /94/$7.00
2 Ann Thorac Surg HATILER ET AL 1349 system records, it took an average of 15 minutes for them to review each chart. Checks by physicians confirmed the accuracy of the data for the initial study patients. Chart reviews are now conducted solely by these trained personnel. This information was stored in the STS database, but was also available locally for inhouse use where data were extracted and subjected to statistical analyses. The statistical techniques applicable to the STS database have recently been described in detail by Edwards and associates [2]. Preoperative risk factors were examined by univariate analysis using a JI technique with two-by-two contingency tables and one degree of freedom. Multivariate analysis was carried out using step-wise, logistic regression to determine those variables having an independent impact on patient survival. Calculated p values less than 0.05 were considered statistically significant. The risk model developed for the STS database was used to examine the effect of multiple risk factors as they pertain to individual patient survival. This model uses a modification of the bayesian algorithm and has been validated using a training set/test set approach. Patients can thus be grouped according to their predicted probability of operative death. After grouping into risk categories, the observed mortality in our patient population was compared with the preoperative predicted mortality. Using these same groupings, morbidity and length of hospital stay were readily extracted from the STS database. Short-term follow-up in our patient population was accomplished either through clinic visits or telephone contacts with the patients or their referring physicians. A questionnaire was administered to determine the New York Heart Association class and the patient's subjective assessment of his or her own condition. Results The clinical profiles for our patient sample using the risk factors from the STS database are shown in Table 1 and compared to information recently published from the STS database that covers the years 1980 through 1990 [2]. Our data represent a more recent time interval (1992 to 1993), and reflect a higher percentage of morbid risk factors in our patient population than that for the STS database. The mortality statistics as derived from the STS database for our sample of 728 patients are depicted in Table 2. The predicted mortality rate is high (6.94%) and reflects, in part, the activity of a high-risk cardiac surgery service that functions as a separate entity within our institution. The overall observed mean mortality (3.98%) for these patients, however, is significantly lower than the predicted mortality (p < 0.005). The predicted versus the observed mortalities for the various risk-stratified groups as derived from the risk model developed for the STS database are depicted in Figure 1. The upper and lower curves represent the calculated range for the risk interval. The data do indicate that the mortality associated with higher-risk patients does not exceed the predicted norm. Not included in the data depicted in Figure 1 are 13 patients with a predicted risk exceeding 50% and an observed mortality rate of 30.8%. Table 1. Summary of Study Patient Profiles as Compared With STS National Database Patient Profiles" STS Database" (% with (% with risk factor; risk factor; Risk Factor n = 728) n = 78,927) Age <70 years >70 years Female Male White Tobacco abuse Family history of coronary artery disease Renal failure Diabetes Hypertension Morbid obesity Hypercholesterolemia Pulmonary hypertension Cerebrovascular disease Cardiomegaly Chronic obstructive pulmonary disease Immunosuppressive treatment Percutaneous transluminal coronary angioplasty <6 hours before CABG Myocardial infarction < days before CABG Myocardial infarction > days before CABG Cardiogenic shock Arrhythmia Unstable angina Intravenous nitrates Intravenous inotropic agents New York Heart Association class I II III IV First operation Reoperation Elective operation Nonelective operation Single-vessel disease Double-vessel disease Triple-vessel disease Preoperative intraaortic balloon pump Ejection fraction < > a Data on these 728 patients were gathered in 1992 and the STS database were gathered from 1980 through 1990 [2]. CABG = coronary artery bypass grafting; Surgeons. b Data on STS = The Society of Thoracic
3 1350 HATILER ET AL Ann Thorac Surg Table 2. The Society of Thoracic Surgeons Risk Stratification Analysis Variable Prediction of operative mortality Sample size for study (No.) Observed mortality in sample (No.) Observed mean mortality Predicted mean mortality Range of predicted mortality in sample Minimum Maximum Standard deviation of predicted mortality Standard error of predicted mortality >I analysis of results predicted versus observed mortality Corrected >I statistic p Value for >I statistic Mortality Groups (Bars = Observed Mortality) Value % 6.94% 0.17% 58.56% <0.005 The risk factors listed in Table 3 were found to be statistically significant in predicting mortality in our patient sample. In addition to cardiogenic shock, the need for intravenously administered nitrates preoperatively, emergency procedures, and a preoperative intraaortic balloon pump for managing hemodynamic instability, as well as the patient being in New York Heart Association class IV, were all found to be highly significant risk factors (mortality risk present versus mortality risk absent; p < 0.005). The risk ratio is derived by dividing the mortality rate with the risk present by the mortality rate with the risk absent. As an example, a patient requiring inotropic agents preoperatively had a 5.1 times greater likelihood of dying after coronary artery bypass grafting at our institution than did a patient not requiring inotropic agents preoperatively. The predicted-risk intervals, as determined preoperatively, and the observed morbidity and length of stay (procedure to discharge) are given in Table 4. The utility of the STS preoperative risk categories is evident as they pertain to postoperative complications. The average number of complications per patient increased in a linear 60% 50% "C 40% Gl. ū 30% "C Gl... II.. 20% % Mortality 10% 2.21% 0% 0-5% 5-10% 10-20% 20-30% 30-50% Fig 1. Predicted mortality for The Society of Thoracic Surgeons model and actual observed mortality for patients in various preoperative risk categories. Not in the data depicted are 13 patients with a predicted risk exceeding 50% and an observed mortality rate of 30.8%. Table 3. Univariate Analysis of Preoperative Risk Variables Found to be Statistically Significant for Entire Population Group (n = 728) Mortality Mortality Risk p Risk Variable (risk present) (risk absent) Ratio Value" Morbid obesity 3/18 (16.67%) 26/710 (3.66%) 4.6 <0.050 Time from 2/8 (25.00%) 27/718 (3.76%) 6.6 <0.050 failed PTCA to CABG <6 hours Prior 12/136 (8.82%) 8/309 (2.59%) 3.4 <0.010 myocardial infarction <21 days Cardiogenic 7/25 (28.00%) 22/703 (3.13%) 8.9 <0.005 shock Intravenous 13/152 (8.55%) 16/576 (2.78%) 3.1 <0.005 nitrates preoperatively Inotropic 3/ %) 26/712 (3.65%) 5.1 <0.025 agents preoperatively New York 17/230 (7.39%) 12/490 (2.45%) 3.0 <0.005 Heart Association class IV Nonelective 18/ %) 11/548 (2.01%) 5.0 <0.005 procedure Preoperative 11/ %) 18/659 (2.73%) 5.8 <0.005 intraaortic balloon pump Ejection 8/ %) 21/659 (3.19%) 3.6 <0.05 fraction <0.30 a it? analysis of results (mortality risk present versus mortality risk absent). PTCA = percutaneous trans CABG = coronaryarterybypass grafting; luminal coronary angioplasty. fashion as the predicted risk became progressively greater. Patients in the greater than 30% predicted-risk category sustained an average of three complications per patient, with two-thirds of patients experiencing complications. Short-term follow-up was obtained in 94% of the 149 patients categorized preoperatively into high-risk (>10%) groups (Table 5). As an example, of the 36 patients with a preoperative risk assessment of greater than 30%, there were seven hospital deaths (19.4%). Of the remaining 27 patients (2 were lost to follow-up), 8 (29.6%) were dead at a mean follow-up of 6.4 months. Of the 19 patients available for follow-up, 18 (94.7%) showed an improvement in their New York Heart Association class of at least two grades. A lesser number (78.9%) felt better subjectively. Comment Using the statistical techniques available through the STS database, we have analyzed our 2-year experience with isolated coronary artery bypass grafting. As relatively recent subscribers to this system, we were interested in determining the validity of these results as they relate to our practice. The comparison of predicted and observed
4 Ann Thorae Surg HATTLER ET AL 1351 Table 4. Univariate Analysis of Morbidity and Length of Hospital Stay Comparing Low-Risk and High-Risk Patient Groups The Society of Thoracic Surgeons Predicted-Risk Intervals 0%-5% 5%-10% 10%-20% 20%-30% >30% Complication (n = 453) (n = 126) (n = 96) (n = 17) (n = 36) Reoperative bleeding (%) a Perioperative myocardial infarction (%) Infection (%) Mediastinal b Septicemia b Stroke (%) Permanent a b Transient Ventilator >5 days (%) a 1O.42 b b b Renal failure (no dialysis) (%) b b b Dialysis required (%) a b b Heart block-permanent (%) Cardiac arrest (%) a a b Anticoagulant complication (%) b Tamponade (%) b Gastrointestinal complication (%) b 1O.42 b b b Multisystem failure (%) a b Inhospital mortality (%) a b Average No. complications per patient a b Patients having complications (%) " b Length of stay-procedure to discharge ± ± b ± b ± c ± b (days ± SD) a p < versus 0-5% group. SD = standard deviation. b P < versus 0-5% group. c p < versus 0-5% group. mortality rates revealed that patients in various risk categories at our institution are being cared for in a manner that meets standards established by the STS database. The small numbers of patients in groups at greater risk makes Table 5. Short-Term Follow-Up in High-Risk Patients Patients (No.) Mean follow-up (mo. ± SD) Lost to follow-up (No. of patients) Follow-up mortality Patient's assessment Better Worse Same Improvement in New York Heart Association class SD = standard deviation. The Society of Thoracic Surgeons Predicted-Risk Intervals 10%-20% (n = 89) 9.9 ± /84 (6.0%) 58/79 (73.4%) 13/7906.1%) 8/7900.1%) 71/79 (89.9%) 20%-30% (n = 15) 5.9 ± 4.4 2/1404.3%) 9/12 (75.0%) 1/12 (8.3%) 2/1206.7%) 11/12 (91.7%) >30% (n = 29) 6.4 ± /27 (29.6%) 15/19 (78.9%) 3/1905.8%) 1/19 (5.3%) 18/19 (94.7%) any conclusion relative to predicted versus observed mortality less reliable (see Fig 1). However, if those deaths in high-risk (>10%) patients that occur during short-term follow-up are included (see Table 5), the observed mortality in each risk category then lies within the range of the predicted mortality. This suggests that, in high-risk patients with numerous associated risk factors, the hazard function as defined by Kirklin and Barratt-Boyes [4] extends beyond the traditional time interval for an operative death to include the early months after discharge from the hospital. Other models besides that of the STS have been used to predict operative risk [5-8]. These have recently been reviewed [2]. In general, most institutional models consist of smaller sample sizes, and their ability to accurately predict outcomes has been found to provide useful results of interest largely to local users. Interest in the STS model, however, has been prompted by the need for a system that goes beyond any local institutional needs to a more flexible and complete database made up of large numbers of patients and against which individual outcomes can be measured over time and as patient characteristics may change [2, 9, 10]. Even early users of the STS database can derive useful data by arranging relatively small numbers of patients into risk category groups. To the extent that the STS database represents a broad national experience, it forms a basis for tracking trends in surgical outcome within various risk categories. Our analyses of patients' preoperative risk through STS modeling have provided not only postoperative correlations
5 1352 HATTLER ET AL Ann Thorac Surg 1994;58:] with mortality data, but also correlations with morbidity and length of hospital stay. In addition, at short-term follow-up, a significant mortality (24.3%) was identified in the first 6 to 8 months after operation in patients with a greater than 20% predicted mortality. These data help, therefore, to quantify the risks, morbidity, and consumption of resources associated with operations in seriously ill patients with coronary artery disease. They should not be used, however, as the only variable in the decision-making process concerning the management of individual patients at increased risk, as the majority of patients in these categories had shown improvement in their New York Heart Association classification on short-term follow-up. There are no data to allow adequate comparison of the natural history of patients in these same high-risk categories. Even death rates for patients on our waiting list for cardiac transplantation with ejection fractions similar to those in the high-risk patients were unsuitable for comparison because they lacked comparable comorbid conditions. The Health Care Financing Administration continues to collect and publish data on mortality statistics for all hospitals performing coronary artery bypass grafting on Medicare patients. Many states now follow a practice similar to that adopted by New York and Pennsylvania in publishing not only hospital, but also physician-specific, mortality rates [11]. Objections have been raised to both the Health Care Financing Administration and various local state systems, criticizing them as being "insufficiently sensitive to make valid inferences about the quality or effectiveness" of various outcome criteria [12, 13]. The model used by the Pennsylvania Health Care Cost Containment Council (Medis), a model with which we are most familiar, has been scrutinized for its ability to provide valid information on risk-adjusted mortality rates to consumers in Pennsylvania. The model has been found to lack sensitivity in its ability to portray comorbid conditions and to assess accurately the severity of illness for each patient entered into the state's database [12]. More specifically, risk factors that are recognized as important (ie, ejection fraction, left main occlusive disease, urgent failed percutaneous transluminal coronary angioplasty, acute cardiac catheterization emergencies, requirement for preoperative intraaortic balloon pump, and preoperative need for intravenously administered inotropic agents) are not recognized by this model [11]. Of even greater concern is the fact that each patient's risk-adjusted mortality and morbidity statistics are partly determined by a derived admission severity grouping. This grouping is arrived at by using a system that assigns a score to each entry from a list of key clinical findings. For each patient's hospital chart, the key clinical findings are searched for during a review of the admission record. After the key clinical findings list is compared with the patient's chart, missing data are recorded as normal data. The admission severity grouping is not revised if the patient, days later and before operation, suffers a myocardial infarction and cardiogenic shock develops. The patient's status on admission to the operating room can, consequently, be ignored. We have found that 12% of the patients at our institution with an admission severity grouping of 1 (0.2% to 1.1% risk) have an STS database-predicted mortality that exceeds 10%. The system is therefore particularly onerous to institutions that attract high-risk patients in unstable conditions [14]. The STS along with the American Medical Association have clearly stated their support for accountability and the release to the public of risk-adjusted hospital and physician-specific data on coronary artery bypass grafting when the data are accurate, carefully gathered, and complete, and when the statistical analyses used are demonstrated to be valid by peer review [12, 15]. In this era of close scrutiny, it is imperative that cardiothoracic surgeons be empowered in their dealings with various agencies by a database that approaches a national average against which individual performance can be measured. The extensive national database established by the STS represents a beginning in arriving at this goal. It will be important for many other groups to confirm its utility. We thank Dr Fred H. Edwards, Dr Richard E. Clark, and Mr Marc Schwartz for their assistance and helpful suggestions, and also Rhonda J. White for her technical assistance. References 1. Data analyses of The Society of Thoracic Surgeons National Cardiac Surgery Database. The third year. Minneapolis: Summit Medical Systems, January Edwards FH, Clark RE, Schwartz M. Coronary artery bypass grafting: The Society of Thoracic Surgeons national database experience. Ann Thorac Surg 1994;57: The Society of Thoracic Surgeons National Cardiac Surgery Database manual for data managers. Minneapolis: Summit Medical Systems, August Kirklin JW, Barratt-Boyes BG, eds. The generation of knowledge from information, data, and analyses. In: Cardiac Surgery, 2nd ed. New York: Churchill Livingstone, 1993: Junod FL, Harlan BI, Payne I, et al. Preoperative risk assessment in cardiac surgery: comparison of predicted and observed results. Ann Thorac Surg 1987;43: Parsonnet V, Dean 0, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79: Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York state. JAMA 1990;264: Higgins TL, Estafanous FG, Loop FD. Stratification of morbidity and mortality outcome by pre-operative risk factors in coronary artery bypass patients. JAMA 1992;267: Edwards FH, Graeber GM. The theorem of Bayes as a clinical research tool. Surg Gynecol Obstet 1987;165: Edwards FH, Albus RA, Zajtchuk R, Graeber GM, Barry M. A quality assurance model of operative mortality in coronary artery surgery. Ann Thorac Surg 1989;47: The Pennsylvania Health Care Cost Containment Council. Coronary artery bypass graft surgery: a technical report. Harrisburg, PA: The Pennsylvania Health Care Cost Containment Council, Report of the Ad Hoc Committee on physician-specific mortality rates for cardiac surgery. Ann Thorac Surg 1993;56: Green I, Wintfeld N, Sharkey P, Passman LJ. The importance of severity of illness in assessing hospital mortality. JAMA 1990;263: Greenfield S, Aronou HU, Elashoff RM, Watanabe D. Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA 1988;260: American Medical Association Policy Compendium. Chicago: American Medical Association, 1993:131-2.
Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting
Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Tuula S. O. Kurki, MD, and Matti Kataja, PhD Heart Center, Deaconess Hospital, and National Public Health Institute,
More informationRisk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery
Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationCardiac disease is well known to be the leading cause
Coronary Artery Bypass Grafting in Who Require Long-Term Dialysis Leena Khaitan, MD, Francis P. Sutter, DO, and Scott M. Goldman, MD Main Line Cardiothoracic Surgeons, Lankenau Hospital, Jefferson Health
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationIn two articles in this supplement [1, 2], the conceptual
Criteria by Which to Evaluate Risk-Adjusted Outcomes Programs in Cardiac Surgery Jennifer Daley, MD Health Services Research and Development and Department of Medicine, Brockton/West Roxbury Veterans Affairs
More informationTechnical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005
Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 The Pennsylvania Health Care Cost Containment Council April 2007 Preface This document serves as a technical supplement to
More informationThe Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models
The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models A. Laurie W. Shroyer, PhD, Laura P. Coombs, PhD, Eric D. Peterson, MD, Mary C. Eiken, MSN, Elizabeth R. DeLong, PhD,
More informationEvidence-based operational and strategic behavior of
Closing the Loop: Optimizing Physicians Operational and Strategic Behavior Paul T. Sergeant, MD, PhD, and Eugene H. Blackstone, MD Katholieke Universiteit Leuven, Leuven, Belgium, and The Cleveland Clinic
More informationT Ad Hoc Committee of The Society of Thoracic Surgeons
The Society of Thoracic Surgeons National Database Status Report Richard E. Clark, MD Chairman, Ad Hoc Committee* to Develop a National Database for Thoracic Surgery This report describes the development
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationCardiac surgery in Victorian public hospitals, Public report
Cardiac surgery in Victorian public hospitals, 2009 10 Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Authors: DT Dinh, L Tran, V Chand, A Newcomb, G Shardey, B Billah
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationery: Comparison of Predicted and Observed Resu ts
Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,
More informationCoronary artery bypass graft (CABG) operations have
Variation in Hospital Rates of Intraaortic Balloon Pump Use in Coronary Artery Bypass Operations William A. Ghali, MD, MPH, Arlene S. Ash, PhD, Ruth E. Hall, MSc, and Mark A. Moskowitz, MD Health Care
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationBUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting
BUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting Arthur J. Hartz, MD, PhD, Evelyn M. Kuhn, PhD, Kenneth L. Kayser, MS, and W. Dudley Johnson, MD Department of Family and Communitv
More informationLink between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis.
Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention Rabah M, Mason D, Muller D W, Hundley R, Kugelmass
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationAppendix 1: Supplementary tables [posted as supplied by author]
Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial
More informationBalloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C
Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C Record Status This is a critical abstract of an economic evaluation that meets
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationAPPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10
Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationTHE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE
THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE Washington University grants permission to use and reproduce the The Importance of Comorbidity
More informationAccepted Manuscript. Simulating the trajectory of off-pump surgery- the heroic defense of the homograft. Ari A. Mennander, MD PhD
Accepted Manuscript Simulating the trajectory of off-pump surgery- the heroic defense of the homograft Ari A. Mennander, MD PhD PII: S0022-5223(18)31728-8 DOI: 10.1016/j.jtcvs.2018.05.112 Reference: YMTC
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationCopyright by ICR Publishers 2005
Does EuroSCORE Predict Length of Stay and Specific Postoperative Complications after Heart Valve Surgery? Ioannis K. Toumpoulis 1,2, Constantine E. Anagnostopoulos 1,2 1 Columbia University College of
More informationSupplementary Online Content
Supplementary Online Content Khera R, Dharmarajan K, Wang Y, et al. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction,
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationPatients Treated by Cardiologists Have a Lower In-Hospital Mortality for Acute Myocardial Infarction
885 Patients Treated by Cardiologists Have a Lower In-Hospital Mortality for Acute Myocardial Infarction PAUL N. CASALE, MD, FACC, JAYNE L. JONES, MPH,* FLOSSIE E. WOLF, MS,* YANFEN PEI, MS,* L. MARLIN
More informationCoronary artery bypass grafting (CABG) is one of the most intensely scrutinized
Surgery for Acquired Cardiovascular Disease Novick et al Direct comparison of risk-adjusted and non risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes Richard J. Novick, MD, a Stephanie
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationIntraoperative and Postoperative Risk Factors for Respiratory Failure After Coronary Bypass
Intraoperative and Postoperative Risk Factors for Respiratory After Coronary Bypass Charles C. Canver, MD, and Jyotirmay Chanda, MD, PhD Division of Cardiothoracic Surgery, The Heart Institute, Albany
More informationDifferent results are reported for surgical myocardial
Surgical Revascularization for Acute Coronary Insufficiency: Analysis of Risk Factors for Hospital Mortality Biagio Tomasco, MD, Antonino Cappiello, MD, Rosario Fiorilli, MD, Archimede Leccese, MD, Raniero
More informationRisk of Not Being Discharged Home After Isolated Coronary Artery Bypass Graft Operations
Risk of Not Being Discharged Home After Isolated Coronary Artery Bypass Graft Operations James Edgerton, MD, Giovanni Filardo, PhD, MPH, William H. Ryan, MD, William T. Brinkman, MD, Robert L. Smith, MD,
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationDoes preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?
Ad et al Acquired Cardiovascular Disease Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? Niv Ad, MD, a Scott D. Barnett, PhD,
More informationOutcome after coronary artery bypass grafting
ICU Admission Score for Predicting Morbidity and Mortality Risk After Coronary Artery Bypass Grafting Thomas L. Higgins, MD, Fawzy G. Estafanous, MD, Floyd D. Loop, MD, Gerald J. Beck, PhD, Jar-Chi Lee,
More informationSurgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018
Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac
More informationAs the proportion of the elderly in the
CANCER When the cancer patient is elderly, how do you weigh the risks of surgery? Marguerite Palisoul, MD Dr. Palisoul is Fellow in the Department of Obstetrics and Gynecology, Division of Gynecologic
More informationThere are several reasons for studying long-term results
Late Outcome and Quality of Life After Complicated Heart Operations Kristina Söderlind, MD, Hans Rutberg, MD, PhD, and Christian Olin, MD, PhD Departments of Cardiothoracic Anaesthesia and Intensive Care
More informationNational VA Oncology Symposium Presentation for any other intended purpose.
THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS 5 TH ANNUAL NATIONAL VA ONCOLOGY SYMPOSIUM PRESENTATION COPYRIGHT NOTICE Washington University grants
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationSupplementary Online Content
Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable
More informationA Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty
JACC Vol. 33, No. 1 January 1999:63 72 63 INTERVENTIONAL CARDIOLOGY A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty EDWARD
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationOccurrence of Bleeding and Thrombosis during Antiplatelet therapy In Non-cardiac surgery. A prospective observational study.
Occurrence of Bleeding and Thrombosis during Antiplatelet therapy In Non-cardiac surgery A prospective observational study OBTAIN Study Statistical Analysis Plan of Final Analysis Final Version: V1.1 from
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationAtrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database
Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD, Sarah Milford-Beland, MS, Karl F. Welke, MD, T. Bruce
More informationRisk-prediction for postoperative major morbidity in coronary surgery
European Journal of Cardio-thoracic Surgery 35 (2009) 760 768 www.elsevier.com/locate/ejcts Risk-prediction for postoperative major morbidity in coronary surgery Pedro E. Antunes, José Ferrão de Oliveira,
More informationPolicy Specific Section: May 16, 1984 April 9, 2014
Medical Policy Heart Transplant Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Transplant Original Policy Date: Effective Date: May 16, 1984 April 9, 2014 Definitions
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery
ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative
More informationPrediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm
Nephrol Dial Transplant (2003) 18: 77 81 Original Article Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm Bjørn O. Eriksen 1, Kristel R.
More informationRecording and Evaluation of Co-Morbidity - An Update. Jill Birch University of Manchester
Recording and Evaluation of Co-Morbidity - An Update Jill Birch University of Manchester Introduction Co-morbidity included in Adult cancer datasets from outset Measures to be used uncertain Uncertainty
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationWhy is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager
Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition
More informationInter-regional differences and outcome in unstable angina
European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International
More informationEffect of Body Mass Index on Early Outcomes in Patients Undergoing Coronary Artery Bypass Surgery
Journal of the American College of Cardiology Vol. 42, No. 4, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00777-0
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationDoes the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?
Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,
More informationTable S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture
Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationP tality and postoperative complications, have been
Bayesian-Logit Model for Risk Assessment in Coronary Artery Bypass Grafting Guillermo Marshall, PhD, A. Laurie W. Shroyer, PhD, Frederick L. Grover, MD, and Karl E. Hammermeister, MD Denver Department
More informationAcquired Cardiovascular Disease
Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery Nikolaos Bonaros, MD, a Diana Hennerbichler,
More informationMajor Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model
Major Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model Andrzej Kansy, MD, PhD, Jeffrey P. Jacobs, MD, PhD, Andrzej Pastuszko, MD, PhD, Małgorzata Mirkowicz-Małek,
More informationLeft Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark
More information2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)
2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse
More informationPreoperative tests (update)
National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix N: Research recommendations April 2016 Developed
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationJournal of the American College of Cardiology Vol. 42, No. 10, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 10, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.05.007
More informationSTS CABG Composite Quality Rating. Participant STS Period Ending 12/31/2016
STS CABG Composite Quality Rating Quality Participant Score STS Mean Participant Distribution of Participant Scores Domain (98% CI) Participant Score Rating = STS Mean Jan 06 - Dec 06 Overall Jan 06 -
More informationModeling and Risk Prediction in the Current Era of Interventional Cardiology
Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.
More informationVariation in Mortality Risk Factors With Time After Coronary Artery Bypass Graft Operation
CARDIOVASCULAR Variation in Mortality Risk Factors With Time After Coronary Artery Bypass Graft Operation Dexiang Gao, PhD, Gary K. Grunwald, PhD, John S. Rumsfeld, MD, PhD, Todd Mackenzie, PhD, Frederick
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationEPO-144 Patients with Morbid Obesity and Congestive Heart Failure Have Longer Operative Time and Room Time in Total Hip Arthroplasty
SESUG 2016 EPO-144 Patients with Morbid Obesity and Congestive Heart Failure Have Longer Operative Time and Room Time in Total Hip Arthroplasty ABSTRACT Yubo Gao, University of Iowa Hospitals and Clinics,
More information11/19/2013. Cardiac Rehabilitation Coverage and Documentation Requirements. Phases of Cardiac Rehabilitation. Phase II
Cardiac Rehabilitation Coverage and Documentation Requirements Phases of Cardiac Rehabilitation Phase I: Acute in-hospital phase of CR Phase II: is the initial outpatient phase of the program Phase III:
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationThe American Experience
The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior
More informationUniversity of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives
Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More information